Vafseo Tablets 150mg, containing Vadadustat, is manufactured by Mitsubishi Tanabe Pharma (YJ code: 3999050F1020, standard: 150mg 1 tablet). Vadadustat is a hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor indicated for the treatment of anemia caused by chronic kidney disease (CKD) in adults who have been receiving dialysis. It helps to increase red blood cell production.
Vafseo Tablets 150mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →